Monoclonal antibodies targeting CD47 enabled the phagocytosis of patient-derived lung cancer cells and CSCs in vitro and inhibited the in vivo growth of xenografted tumors developed from patient-derived lung cancer cells or CSCs. The gene discussed is CD47; the disease is lung cancer.